Chicago Equity Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-6,124
| Closed | -$260K | – | 825 |
|
2016
Q2 | $260K | Buy |
6,124
+148
| +2% | +$6.28K | 0.01% | 579 |
|
2016
Q1 | $394K | Sell |
5,976
-9,781
| -62% | -$645K | 0.01% | 509 |
|
2015
Q4 | $979K | Buy |
15,757
+302
| +2% | +$18.8K | 0.03% | 363 |
|
2015
Q3 | $1.04M | Buy |
15,455
+13,417
| +658% | +$899K | 0.03% | 356 |
|
2015
Q2 | $198K | Sell |
2,038
-1,514
| -43% | -$147K | 0.01% | 452 |
|
2015
Q1 | $332K | Buy |
3,552
+810
| +30% | +$75.7K | 0.01% | 377 |
|
2014
Q4 | $244K | Sell |
2,742
-2,274
| -45% | -$202K | 0.01% | 361 |
|
2014
Q3 | $346K | Buy |
5,016
+3,399
| +210% | +$234K | 0.01% | 360 |
|
2014
Q2 | $92K | Buy |
+1,617
| New | +$92K | ﹤0.01% | 434 |
|